Nuvation Bio Inc.
NUVB
$2.18
$0.020.93%
NYSE
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 685.56% | -49.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 685.56% | -49.34% | |||
| Cost of Revenue | 178.28% | 12.47% | |||
| Gross Profit | 289.72% | -995.45% | |||
| SG&A Expenses | 33.48% | 21.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.17% | -89.65% | |||
| Operating Income | -12.14% | 89.77% | |||
| Income Before Tax | -19.98% | 91.09% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -19.98% | 91.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -19.98% | 91.09% | |||
| EBIT | -12.14% | 89.77% | |||
| EBITDA | -12.07% | 89.80% | |||
| EPS Basic | 2.59% | 92.03% | |||
| Normalized Basic EPS | 2.55% | 92.03% | |||
| EPS Diluted | 2.59% | 92.03% | |||
| Normalized Diluted EPS | 2.55% | 92.03% | |||
| Average Basic Shares Outstanding | 23.16% | 11.78% | |||
| Average Diluted Shares Outstanding | 23.16% | 11.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||